Recon: Canadian Fund Buys Keytruda Rights from UK's LifeArc for £1B - Regulatory Focus

Submitted by Anonymous (not verified) on Mon, 05/20/2019 - 18:01

Recon: Canadian Fund Buys Keytruda Rights from UK's LifeArc for £1B  Regulatory FocusWelcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US. Gates-backed Schrödinger raises $110m for new ...